Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1200292017 | Procainamide hydrochloride 375mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1213350015 | Procainamide hydrochloride 375mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3470653013 | Product containing procainamide hydrochloride 375 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3489964010 | Product containing procainamide hydrochloride 375 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3501288010 | Procainamide hydrochloride 375 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3568230010 | Product containing only procainamide hydrochloride 375 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3568231014 | Product containing only procainamide hydrochloride 375 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3682323018 | Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3682324012 | Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral tablet | Is a | Product containing procainamide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral tablet | Is a | Product containing procainamide in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral tablet | Has active ingredient | Procainamide hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral tablet | Has manufactured dose form | Oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral tablet | Has active ingredient | Procainamide hydrochloride | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral tablet | Has basis of strength substance | Procainamide hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 375 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral tablet | Has precise active ingredient | Procainamide hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral tablet | Is a | Product containing only procainamide in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR